AustralieFrV1, Main, Exploration, bibRecord, 009722

Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management

Identifieur interne : 009722 ( Main/Exploration ); précédent : 009721; suivant : 009723

Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management

Auteurs : Anna S. Lok [États-Unis] ; Fabien Zoulim [France] ; Stephen Locarnini [Australie] ; Angeline Bartholomeusz [Australie] ; Marc G. Ghany [États-Unis] ; Jean-Michel Pawlotsky [France] ; Yun-Fan Liaw [Taïwan] ; Masashi Mizokami [Japon] ; Carla Kuiken [États-Unis]

Source :

Hepatology : (Baltimore, Md.) [ 0270-9139 ] ; 2007.

RBID : Pascal:07-0342113

Descripteurs français

Pascal (Inist)
- Hépatite virale B, Interféron, Antiviral, Normalisation, Dosage, Recommandation, Traitement, Gastroentérologie.
Wicri :
- topic : Normalisation, Recommandation.

English descriptors

KwdEn :
- Antiviral, Assay, Gastroenterology, Interferon, Recommendation, Standardization, Treatment, Viral hepatitis B.

Abstract

Substantial advances have been made in the treatment of chronic hepatitis B in the past decade. Approved treatments for chronic hepatitis B include 2 formulations of interferon and 4 nucleos(t)ide analogues (NAs). Sustained viral suppression is rarely achieved after withdrawal of a 48-week course of NA therapy, necessitating long, and in many cases, indefinite treatment with increasing risk of development of drug resistance. Antiviral resistance and poor adherence are the most important factors in treatment failure of hepatitis B. Thus, there is a need to standardize nomenclature relating to hepatitis B antiviral resistance, and to define genotypic, phenotypic, and clinical resistance to NA therapy.

Affiliations:

Australie, France, Japon, Taïwan, États-Unis
Auvergne-Rhône-Alpes, Rhône-Alpes, Île-de-France
Créteil, Lyon

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 003B19
to stream PascalFrancis, to step Curation: 002569
to stream PascalFrancis, to step Checkpoint: 003A55
to stream Main, to step Merge: 00A167
to stream Main, to step Curation: 009722

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management</title>
<author><name sortKey="Lok, Anna S" sort="Lok, Anna S" uniqKey="Lok A" first="Anna S." last="Lok">Anna S. Lok</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Gastroenterology, University of Michigan</s1>
<s2>Ann Arbor, MI</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Ann Arbor, MI</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM, U271; Universite Lyon I; Hospices Civils de Lyon</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Locarnini, Stephen" sort="Locarnini, Stephen" uniqKey="Locarnini S" first="Stephen" last="Locarnini">Stephen Locarnini</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Victorian Infectious Diseases Reference Laboratory</s1>
<s2>North Melbourne, Victoria</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Victorian Infectious Diseases Reference Laboratory</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bartholomeusz, Angeline" sort="Bartholomeusz, Angeline" uniqKey="Bartholomeusz A" first="Angeline" last="Bartholomeusz">Angeline Bartholomeusz</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Victorian Infectious Diseases Reference Laboratory</s1>
<s2>North Melbourne, Victoria</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Victorian Infectious Diseases Reference Laboratory</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ghany, Marc G" sort="Ghany, Marc G" uniqKey="Ghany M" first="Marc G." last="Ghany">Marc G. Ghany</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Liver Diseases Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pawlotsky, Jean Michel" sort="Pawlotsky, Jean Michel" uniqKey="Pawlotsky J" first="Jean-Michel" last="Pawlotsky">Jean-Michel Pawlotsky</name>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology and INSERM U841, Hopital Henri Mondor, Universite Paris 12</s1>
<s2>Creteil</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Créteil</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liaw, Yun Fan" sort="Liaw, Yun Fan" uniqKey="Liaw Y" first="Yun-Fan" last="Liaw">Yun-Fan Liaw</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Liver Research Unit, Chang Gung University and Memorial Hospital</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mizokami, Masashi" sort="Mizokami, Masashi" uniqKey="Mizokami M" first="Masashi" last="Mizokami">Masashi Mizokami</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences</s1>
<s2>Nagoya</s2>
<s3>JPN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Nagoya</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kuiken, Carla" sort="Kuiken, Carla" uniqKey="Kuiken C" first="Carla" last="Kuiken">Carla Kuiken</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Theoretical Biology and Biophysics Group (T-10), Los Alamos National Laboratory</s1>
<s2>Los Alamos, NM</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Los Alamos, NM</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0342113</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0342113 INIST</idno>
<idno type="RBID">Pascal:07-0342113</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003B19</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002569</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003A55</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">003A55</idno>
<idno type="wicri:doubleKey">0270-9139:2007:Lok A:antiviral:drug:resistant</idno>
<idno type="wicri:Area/Main/Merge">00A167</idno>
<idno type="wicri:Area/Main/Curation">009722</idno>
<idno type="wicri:Area/Main/Exploration">009722</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management</title>
<author><name sortKey="Lok, Anna S" sort="Lok, Anna S" uniqKey="Lok A" first="Anna S." last="Lok">Anna S. Lok</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Gastroenterology, University of Michigan</s1>
<s2>Ann Arbor, MI</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Ann Arbor, MI</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM, U271; Universite Lyon I; Hospices Civils de Lyon</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Locarnini, Stephen" sort="Locarnini, Stephen" uniqKey="Locarnini S" first="Stephen" last="Locarnini">Stephen Locarnini</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Victorian Infectious Diseases Reference Laboratory</s1>
<s2>North Melbourne, Victoria</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Victorian Infectious Diseases Reference Laboratory</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bartholomeusz, Angeline" sort="Bartholomeusz, Angeline" uniqKey="Bartholomeusz A" first="Angeline" last="Bartholomeusz">Angeline Bartholomeusz</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Victorian Infectious Diseases Reference Laboratory</s1>
<s2>North Melbourne, Victoria</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Victorian Infectious Diseases Reference Laboratory</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ghany, Marc G" sort="Ghany, Marc G" uniqKey="Ghany M" first="Marc G." last="Ghany">Marc G. Ghany</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Liver Diseases Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pawlotsky, Jean Michel" sort="Pawlotsky, Jean Michel" uniqKey="Pawlotsky J" first="Jean-Michel" last="Pawlotsky">Jean-Michel Pawlotsky</name>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology and INSERM U841, Hopital Henri Mondor, Universite Paris 12</s1>
<s2>Creteil</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Créteil</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liaw, Yun Fan" sort="Liaw, Yun Fan" uniqKey="Liaw Y" first="Yun-Fan" last="Liaw">Yun-Fan Liaw</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Liver Research Unit, Chang Gung University and Memorial Hospital</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mizokami, Masashi" sort="Mizokami, Masashi" uniqKey="Mizokami M" first="Masashi" last="Mizokami">Masashi Mizokami</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences</s1>
<s2>Nagoya</s2>
<s3>JPN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Nagoya</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kuiken, Carla" sort="Kuiken, Carla" uniqKey="Kuiken C" first="Carla" last="Kuiken">Carla Kuiken</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Theoretical Biology and Biophysics Group (T-10), Los Alamos National Laboratory</s1>
<s2>Los Alamos, NM</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Los Alamos, NM</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Hepatology : (Baltimore, Md.)</title>
<title level="j" type="abbreviated">Hepatology : (Baltim. Md.)</title>
<idno type="ISSN">0270-9139</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Hepatology : (Baltimore, Md.)</title>
<title level="j" type="abbreviated">Hepatology : (Baltim. Md.)</title>
<idno type="ISSN">0270-9139</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Assay</term>
<term>Gastroenterology</term>
<term>Interferon</term>
<term>Recommendation</term>
<term>Standardization</term>
<term>Treatment</term>
<term>Viral hepatitis B</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Hépatite virale B</term>
<term>Interféron</term>
<term>Antiviral</term>
<term>Normalisation</term>
<term>Dosage</term>
<term>Recommandation</term>
<term>Traitement</term>
<term>Gastroentérologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Normalisation</term>
<term>Recommandation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Substantial advances have been made in the treatment of chronic hepatitis B in the past decade. Approved treatments for chronic hepatitis B include 2 formulations of interferon and 4 nucleos(t)ide analogues (NAs). Sustained viral suppression is rarely achieved after withdrawal of a 48-week course of NA therapy, necessitating long, and in many cases, indefinite treatment with increasing risk of development of drug resistance. Antiviral resistance and poor adherence are the most important factors in treatment failure of hepatitis B. Thus, there is a need to standardize nomenclature relating to hepatitis B antiviral resistance, and to define genotypic, phenotypic, and clinical resistance to NA therapy.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
<li>Japon</li>
<li>Taïwan</li>
<li>États-Unis</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
<li>Île-de-France</li>
</region>
<settlement><li>Créteil</li>
<li>Lyon</li>
</settlement>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Lok, Anna S" sort="Lok, Anna S" uniqKey="Lok A" first="Anna S." last="Lok">Anna S. Lok</name>
</noRegion>
<name sortKey="Ghany, Marc G" sort="Ghany, Marc G" uniqKey="Ghany M" first="Marc G." last="Ghany">Marc G. Ghany</name>
<name sortKey="Kuiken, Carla" sort="Kuiken, Carla" uniqKey="Kuiken C" first="Carla" last="Kuiken">Carla Kuiken</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name>
</region>
<name sortKey="Pawlotsky, Jean Michel" sort="Pawlotsky, Jean Michel" uniqKey="Pawlotsky J" first="Jean-Michel" last="Pawlotsky">Jean-Michel Pawlotsky</name>
</country>
<country name="Australie"><noRegion><name sortKey="Locarnini, Stephen" sort="Locarnini, Stephen" uniqKey="Locarnini S" first="Stephen" last="Locarnini">Stephen Locarnini</name>
</noRegion>
<name sortKey="Bartholomeusz, Angeline" sort="Bartholomeusz, Angeline" uniqKey="Bartholomeusz A" first="Angeline" last="Bartholomeusz">Angeline Bartholomeusz</name>
</country>
<country name="Taïwan"><noRegion><name sortKey="Liaw, Yun Fan" sort="Liaw, Yun Fan" uniqKey="Liaw Y" first="Yun-Fan" last="Liaw">Yun-Fan Liaw</name>
</noRegion>
</country>
<country name="Japon"><noRegion><name sortKey="Mizokami, Masashi" sort="Mizokami, Masashi" uniqKey="Mizokami M" first="Masashi" last="Mizokami">Masashi Mizokami</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009722 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009722 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:07-0342113
   |texte=   Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management

Antiviral drug-resistant HBV : Standardization of nomenclature and assays and recommendations for management

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri